Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease

J Infect. 2022 Jun;84(6):e122-e125. doi: 10.1016/j.jinf.2022.02.027. Epub 2022 Feb 28.
No abstract available

Keywords: ChAdOx nCoV-19, vaccine, end-stage renal disease, immunity; SARS-CoV-2.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19
  • Humans
  • Kidney Failure, Chronic* / therapy
  • Natural Killer T-Cells*
  • SARS-CoV-2


  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19